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Epidemiological studies have shown an association between short or disrupted sleep and an increased risk for metabolic disorders.
To assess a possible causal relationship, we examined the eﬀects of experimental sleep disturbance on glucose regulation in Wistar
ratsundercontrolledlaboratoryconditions.Threegroupsofanimalswereused:asleeprestrictiongroup(RS),agroupsubjectedto
moderate sleep disturbance without restriction of sleep time (DS), and a home cage control group. To establish changes in glucose
regulation, animals were subjected to intravenous glucose tolerance tests (IVGTTs) before and after 1 or 8 days of sleep restriction
or disturbance. Data show that both RS and DS reduce body weight without aﬀecting food intake and also lead to hyperglycemia
and decreased insulin levels during an IVGTT. Acute sleep disturbance also caused hyperglycemia during an IVGTT, yet, without
aﬀecting the insulin response. In conclusion, both moderate and severe disturbances of sleep markedly aﬀect glucose homeostasis
and body weight control.
1.Introduction
Sleep and metabolism seem to be related. Epidemiological
studies have established a link between disturbed sleep and
increased risk for the development of obesity and type 2
diabetes [1–4]. These studies revealed that habitual short
sleep is a risk factor, independent of classical risk factors such
as BMI, food intake, and reduced exercise. (For reviews; see
[5–7]). Whether or not these relationships are causal is still a
matter of debate [8].
Experimental studies in both humans and animals have
showncleareﬀectsofsleepdeprivationonbodytemperature,
food intake, body weight gain, and energy expenditure [9–
12]. Sleep deprivation also leads to changes in the activation
ofthesympatheticnervoussystem,toreducedlevelsofleptin
and to increased levels of ghrelin in the general circulation
[13].Finally,anumberofrecentexperimentalstudiessuggest
that even mild sleep disturbance leads to glucose intolerance,
the ﬁrst step in the development of type 2 Diabetes [14, 15].
While epidemiological studies mainly focused on mild
but chronic sleep disturbances, laboratory studies mostly
focus on the consequences of acute and short-lasting sleep
deprivation. Frequent or chronic sleep disruption may
gradually lead to changes in brain and body that are not
noticeable after acute sleep deprivation [16–18]. Yet, studies
on metabolism and glucose regulation under conditions of
mild but chronic sleep disturbance in a controlled experi-
mental setting are scarce [14, 19]. Therefore, in the current
study we applied an animal model to investigate the eﬀect of
chronically disturbed sleep on glucose homeostasis. To this
end, rats were subjected to a series of intravenous glucose
tolerance tests (IVGTTs) before and after a period of either
moderate sleep disturbance or severe sleep restriction. To
compare the eﬀects of acute and chronic sleep disturbance,
the experiment was performed after a period of 1 or 8 days
of sleep disturbance.
2. Methods
2.1. Animals and Housing. Male Wistar rats (weight ±320g;
Harlan Netherlands BV, Horst, The Netherlands) were
individually housed in Plexiglas cages in a climate-controlled
room (21◦C ± 1) under a 12h:12h light-dark cycle (lights
onat10:00AM).Animalsweremaintainedadlibonmedium2 International Journal of Endocrinology
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Figure 1: Schematic overview of the sleep disturbance protocols for
the restricted sleep group (RS), disturbed sleep group (DS), and
control group. For each treatment group, periods of wakefulness
induced by forced locomotion are shown in light grey. The RS
group was subjected daily to one consolidated block of 20-hour
forced activity while the DS group was subjected to blocks of 2-3-
hourforcedactivityinterspersedby3-4-hourblocksofrest.Control
animals were left undisturbed.
fat food (45% fat; Arie Blok Diervoeding B.V., Woerden,
The Netherlands). Water was available ad lib throughout the
study. Food intake and body weights were measured daily.
Experiments were approved by the Ethical Committee of
Animal Experiments of the University of Groningen.
2.2. Surgery. All animals were instrumented with chronic
heart catheters bilaterally in the jugular vein [20] allowing
stress free blood sampling during an intravenous glucose
tolerance test (IVGTT). Surgeries were carried out under
general isoﬂurane (2%) anesthesia. Animals had at least 10
days to recover before the start of the experiments. Cannulas
were checked every week for patency.
2.3. Sleep Restriction and Sleep Disturbance. The animals
were divided over three groups (see Figure 1): a sleep
restricted group (restricted sleep: RS), a moderately sleep
disturbed group (disturbed sleep, DS), and a home cage
control group (controls). The sleep restricted animals (RS)
were allowed to sleep in their home cage for only 4 hours
per day at the beginning of the light phase. During the
remaining 20 hours, the rats were kept awake by placing
them in slowly rotating drums (diameter 40cm), rotating
at a constant speed of 0.4m/min [17, 18] .T h ea n i m a l so f
the sleep disturbed group (DS) were forced to walk in the
rotating drums for a total of 10 hours/day with the aim
to disturb their normal sleep-wake cycle without restricting
their sleep time. The 10 hours of forced activity in this
group was divided in 4 blocks of 2 or 3 hours with 3 or
4 hours of rest in between (Figure 1). The animals of the
DS group walked at double speed (0.8m/min) and therefore
covered the same distance as the RS animals (0.48km/day).
For comparison, rats run approximately 2-3km/day when
allowed to run voluntarily [21]. Both RS and DS animals
spent the ﬁrst 4h of the light phase in their regular home
cages for IVGTTs and blood sampling. All animals were
habituated to the experimental conditions by placing them
in the drums for 1-2 hours for 3 consecutive days before
the onset of the experiments. Control animals were left
undisturbed in their home cage.
2.4. Intravenous Glucose Tolerance Test and Chemical Anal-
yses. To assess the eﬀects of sleep restriction and/or sleep
disturbance on glucose regulation, rats were subjected to a
series of intravenous glucose tolerance tests (IVGTTs). The
IVGTTs were performed during the third and fourth hour
of the light phase. Food was removed at lights on and rats
were connected to the blood sampling and infusion tubes
at least one hour before the IVGTT. During the IVGTT, a
15% glucose solution was infused for 30 minutes at a rate
of 0.1ml/min. The start of the infusion was designated time
point t = 0 min. Blood samples (0.2ml) for determination of
blood glucose and plasma insulin levels were taken before,
during, and after the infusion of glucose at time points t
= −10, −1, 5, 10, 15, 20, 25, 30, 35, 40, and 50 minutes.
Note that the glucose infusion prevented any hypovolemic
eﬀect of the blood sampling. Blood samples were collected in
EDTA (20µL/ml blood) containing tubes on ice. Blood was
centrifugedat2600gfor10minutesandplasmawasstoredat
−20◦C until analysis. Blood glucose levels were measured by
Hoﬀman’s ferrocyanide method and plasma levels of insulin
were measured by Millepore Rat Insulin Radioimmunoassay
(Linco Research, St Charles, MO, USA).
2.5. Experimental Design. Two experiments were performed.
Experiment 1 was designed to study glucose homeostasis
under conditions where sleep was disrupted or restricted
chronically. In this experiment, the animals were subjected
to an IVGTT before (pre-experimental baseline) and after
an 8-day period of sleep disturbance (RS or DS). Rats that
remained in their home cage without any sleep disturbance
served as controls. Experiment 2 served as a control experi-
mentforthechronicsleepdisturbancestudyandassessedthe
eﬀectsofacutesleepdisturbance.Inthissecondexperimenta
singleIVGTTwasperformedafter1dayofsleepdisturbance.
In both experiments, blood samples were collected for
measurement of glucose and insulin levels. In the second
experiment an additional 0.1ml blood sample was taken at
t = −10 minutes for determination of plasma corticosterone
levels (ImmuChem 125I Corticosterone Radioimmunoassay,
MP Biomedicals, Orangeburg, NY, USA).
2.6. Statistical Analysis. Data are expressed as averages ±
SEM. Body weight is expressed as the change in weight rel-
ative to day 0 (the onset of sleep disturbance). The eﬀects of
RS and DS on food intake and body weight as well as glucose
and insulin responses to IVGTT were tested by comparing
the experimental and control groups with each other and,
in Experiment 1, with the pre-experimental baseline using
repeated measures analysis of variance (ANOVA). When
appropriate, a post hoc Tukey test was applied to establish
diﬀerences between the three groups (controls, RS, and DS).
P<.05 was considered statistically signiﬁcant.
3. Results
Theaverage24-hourfoodintakebefore,during,andafterthe
treatment for the diﬀerent groups is shown in Figure 2(a).
There were neither diﬀerences in food intake between theInternational Journal of Endocrinology 3
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Figure 2: Average daily food intake (a) and body weight (b) in the baseline, experimental, and recovery phase of the experiment for RS
(n = 11), DS (n = 12), and control (n = 7) animals. The horizontal grey bars at the bottom of the graphs represent the 8-day period of RS
or DS. Data are average values ± SEM. Asterisks indicate a signiﬁcant diﬀerence between sleep disturbed (DS and RS) and control animals
(∗P<.01).
3 groups nor changes over time within the groups. Body
weights are shown in Figure 2(b). The RS and DS animals
were signiﬁcantly lower in body weight than the home cage
controls already after 2 days of sleep disturbance (Repeated
Measures ANOVA: F(36,486) = 11.02, P<.001; post hoc
Tukey Test: controls versus RS P<.01 and controls versus DS
P<.01). There were no body weight diﬀerences between the
RS and the DS animals.
Figure 3 depicts the glucose and insulin levels before,
during, and after the 30-minutes intravenous infusion of
glucose, both under baseline (pre-experimental) conditions
and after 8 days of sleep disturbance (RS and DS versus
controls). In all groups, intravenous infusion of glucose
led to an increase in both blood glucose and plasma
insulin levels. After termination of the infusion, both glucose
and insulin returned to pre-infusion levels. Eight days of
sleep disturbance markedly changed the glucose and insulin
responses to an IVGTT. Blood glucose levels were higher and
plasma insulin levels were lower in the RS and DS animals
compared to the pre-experimental IVGTT levels (Glucose
RS: F(10,140) = 10.05, P<.0001; Glucose DS: F(10,160) =
9.64, P<.0001; Insulin RS: F(10,150) = 10.53, P<.0001;
Insulin DS: F(10,160) = 8.97, P<.0001). Also in comparison
to the home cage controls, glucose levels were higher
and insulin levels were lower in both experimental groups
(Glucose: F(20,200) = 3.37, P<.0001; post hoc Tukey Test:
RS versus controls P<.05 and DS versus controls P<.05;
Insulin: F(20,190) = 3.70, P<.0001; post hoc Tukey Test: RS
versus controls P<.01 and DS versus controls P<.05). No
diﬀerences were found between the RS and DS rats.
Figure 4 shows the glucose and insulin levels before,
during, and after the glucose infusion after a single day of
sleep disturbance. In both the RS and DS animals, glucose
levels were signiﬁcantly higher than the levels in undisturbed
home cage controls (F(21,210) = 12.49, P<.0001; post
hoc Tukey Test: RS versus controls P<.001 and DS versus
controls P<.001). There were no diﬀerences between the
groups with regard to the plasma insulin response to an
IVGTT after one day of sleep disturbance.
In Experiment 2, after 1 day of RS or DS, at time point t
= −10 min immediately preceding the IVGTT, plasma levels
of corticosterone were low and not diﬀerent between the
groups (RS: 1.4 ± 0.2µg/dl, DS: 1.3 ± 0.1µg/dl, controls: 2.4
± 0.2µg/dl).
4. Discussion
This study shows that eight days of sleep disturbance
markedly interferes with body weight maintenance and
glucose metabolism in rats. The main ﬁndings are that
(1) chronic sleep disturbance reduces body weight without
changes in food intake; (2) chronic sleep disturbance leads
to hyperglycemia and a concomitant reduction in the insulin
response to an IVGTT; (3) acute sleep disturbance also leads
to hyperglycemia without changes in the insulin response
to an IVGTT; (4) the metabolic eﬀects of moderate sleep
disturbance and more severe sleep restriction are remarkably
similar.
The elevated glucose levels that occurred after both
short- and long-term sleep disturbance conﬁrm the data
from previous studies in humans in which was found that
moderate sleep restriction or even suppression of sleep
intensity without aﬀecting sleep time may lead to glucose
intolerance [14, 15]. In our study, the increase in blood
glucose during the IVGTT already occurred after one day
of sleep disturbance. The data from the chronic sleep4 International Journal of Endocrinology
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Figure 3: Blood glucose and plasma insulin levels in response to a 30-minutes intravenous glucose infusion after 8 days of sleep restriction
(graphs (c) and (f), n = 11), sleep disturbance (graphs (b) and (e), n = 1 2 ) ,o rc o n t r o l( g r a p h s( a )a n d( d ) ,n = 7). Each graph presents
the glucose or insulin proﬁles under pre-experimental baseline conditions (Baseline: open circles) and after 8 days of sleep disturbance
(Experiment: closed circles). The horizontal grey bars at the bottom of each graph represent the 30 minutes of 15% glucose infusion. Data
are average values ± SEM. Asterisks indicate a signiﬁcant diﬀerence between baseline and experimental conditions (∗P<.05).
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Figure 4: Blood glucose (a) and plasma insulin levels (b) in response to a 30-minutes intravenous glucose infusion after 1 day of sleep
restriction (closed triangles, n = 8), sleep disturbance (closed circles, n = 8), or control (open circles, n = 8). The horizontal grey bars at
the bottom of the graphs represent the 30 minutes of 15% glucose infusion. Data are average values ± SEM. Asterisks indicate a signiﬁcant
diﬀerence between sleep restricted rats and controls (∗P<.05) and # indicates a signiﬁcant diﬀerence between sleep disturbed rats and
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disturbance experiment might suggest that the elevated
glucose levels are caused by a reduced insulin response.
However, the ﬁnding of hyperglycemia without changes in
plasma insulin response after acute sleep disturbance makes
this explanation less likely. An alternative explanation might
be that the hyperglycemia is caused by increased HPA-axis
activity reﬂecting the stress of sleep disturbance. To test this
possibility we measured plasma corticosterone levels in the
sleep disturbed animals just prior to the infusion of glucose.
Since corticosterone levels were not diﬀerent between the
groups, elevated HPA-axis activity can also not explain the
hyperglycemia after sleep disturbance. Therefore, the reason
for the hyperglycemia following both short- and long-term
sleep disturbance remains unclear. Our current studies focus
on the hypothesis that this hyperglycemia may be secondary
to changes in hypothalamic orexin, a neuropeptide known
to be involved in both the sleep/wake cycle and glucose
metabolism [22–24]. A number of recent studies suggest that
REM sleep deprivation increases orexin immunoreactivity in
the lateral hypothalamic area and orexin levels in the CSF,
whichmayunderliesomeofthemetabolicchangesdescribed
after restricted or disrupted sleep [25, 26].
Eight days of sleep disturbance caused a reduction in
bodyweighttogetherwithadecreaseinbasallevelsofglucose
and insulin and a decrease in IVGTT levels of insulin. The
literature suggests that the lower levels of glucose and insulin
and the attenuated insulin response to the glucose tolerance
test are most likely a direct consequence of the drop in body
weight [27].
Surprisingly,theweightlossinourratswasnotaccompa-
nied by a change in food intake, which may suggest that sleep
disturbance leads to increased daily energy expenditure. The
latter indeed is supported by data in the literature [11, 28].
Onecauseofanincreasedenergyexpenditureinourprotocol
of sleep disturbance might be the forced locomotion in
the rotating drums. However, one should note that in both
the RS and DS conditions the rats walked only 480m/day,
which is less than 20% of the distance they would voluntarily
run in a running wheel [21]. Furthermore, although long-
term exercise may lead to improved insulin sensitivity and
therefore reduced plasma insulin levels [29], in rats, it does
not lead to extensive weight loss and/or hyperglycemia [30].
Therefore, the decrease in body weight and hyperglycemia in
ourstudyarenotlikelyaresultofthemildincreaseinactivity
involved in our sleep disturbance protocols.
The metabolic changes after sleep disturbance were
similar in the RS and DS animals. This was unexpected
becausethedegreeofsleeprestrictionwasmarkedlydiﬀerent
between the two groups. The DS rats were subjected to a
disruptionofthenormalsleep-wakecyclewithoutrestriction
of their sleep time, whereas the RS rats were genuinely
sleep restricted. Based on this observation, we speculate that
the metabolic consequences of sleep curtailment are mainly
related to the occurrence of frequent sleep interruptions and
a disturbed sleep-wake cycle rather than sleep loss per se. In
other words, it is the quality rather than the quantity of sleep
that is important. Indeed, a recent study in humans found
that suppression of sleep intensity without changes in total
sleep time was suﬃcient to cause glucose intolerance and
a decreased acute insulin response [15]. Patients suﬀering
from obstructive sleep apnea (OSA) provide comparable
evidence [31, 32]. Total sleep time in OSA patients is
not dramatically altered; still there are direct correlations
betweenOSAandobesity,type2diabetes,andcardiovascular
diseases [33] .T h eo p p o s i t ei st r u ea sw e l l :m o d e s tw e i g h t
gain or weight loss leads to a signiﬁcant worsening or
improvement, respectively, of sleep apnea in middle-aged
individuals [34, 35]. Thus, several lines of evidence together
suggest that disturbed sleep by itself is suﬃcient to aﬀect
glucose homeostasis.
In conclusion, our data reveal that disturbance of the
regular sleep-wake rhythm has a marked eﬀect on glucose
homeostasis and body weight control. Sleep disturbance
directly leads to glucose intolerance and hyperglycemia and,
on the long term, to weight loss accompanied with reduced
insulinresponses.Thedatafurthersuggestthatadisturbance
of the normal sleep pattern, even without restriction of total
sleeptime,issuﬃcienttoaﬀectglucosemetabolismandbody
weight maintenance.
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